Tata Chemicals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Smallcap 250 and 0.6 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Tata Chemicals reported Q1 FY26 consolidated revenue from operations of ₹3,719 crore, marginally down ~1.8% YoY from ₹3,789 crore in Q1 FY25, but up ~6% versus Q4 FY25. Consolidated profit before tax jumped to ₹360 crore from ₹269 crore YoY (~34% growth), aided by lower base last year and a ₹48 crore tax reversal relating to earlier years. Profit for the period rose sharply to ₹316 crore from ₹190 crore YoY (~66% growth). Operating margin expanded to 9.92% from 7.94% YoY, reflecting improved cost performance. On a standalone basis, revenue grew ~11.7% YoY to ₹1,169 crore, with PAT up ~13% to ₹307 crore. The auditor (BSR & Co. LLP) issued an unmodified opinion on standalone results and an unmodified limited review conclusion on consolidated results, with no exceptional items in the current quarter.
Strong YoY profit growth, margin expansion, and clean auditor opinion are positive signals for shareholders. However, the slight YoY decline in consolidated revenue and a loss-making Q4 FY25 base partly flatter the comparison, so the underlying demand picture remains mixed.